NASD
| Health Care |
Biotechnology
Rocket Pharmaceuticals Corp. (RCKT)
LAST (3 Apr)
After-Hours (19:57:06 ET)
MARKET CAP
VOLUME
| Open | 5.97 |
| Previous Close | 6.3 |
| Day Range | 5.52 - 5.99 |
| 52-Week Range | 5.52 - 26.98 |
| All-Time High | 77.80 |
| Avg. Volume (50-day) | 1,821,600.6 |
| EPS (TTM) | -2.73 |
| Next Earnings Date | 2025-05-05 (AMC) |
| Last Earnings Date | 2025-02-27 |
| Forward Annual Dividend (Yield) | - |
| Trailing Annual Dividend (Yield) | - |
| Options | Yes |
| P/E Ratio | -2.30 |
| PEG Ratio | - |
| Price to Book | 1.45 |
| Price to Cash Flow | - |
| Price to Free Cash Flow | - |
| Total Sales (TTM) | - |
| Revenue per Share (TTM) | - |
| Shares Outstanding | 106.630 M |
| Share Float (%) | 98.97 M |
| % Held by Institutions | 101.09 |
| Dividends Per Share (TTM) | - |
| Ex-Dividend Date | - |
| +/- EMA(20) | 7.73 (-28.07%) |
| +/- SMA(50) | 9.28 (-40.09%) |
| +/- SMA(200) | 15.41 (-63.92%) |
| 5-Day Perf. | -29.44% |
| 1-Month Perf. | -36.75% |
| 3-Month Perf. | -55.73% |
| 6-Month Perf. | -65.38% |
| YTD Perf. | -55.77% |
| 1-Year Perf. | -78.14% |
| RSI(14) | 26.13 |
| ATR(14) | 0.61 |
| ADX(14) | 42.66 |
| Beta (5Y) | 1.66 |
FOR STOCKCHARTS MEMBERS ONLY
Unlock earnings and revenue history when you join StockCharts
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
RCKT
Rocket Pharmaceuticals Corp.
Sector: Health Care
Industry: Biotechnology
Employees: 299
Description
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
RCKT has triggered the following predefined scans:
| P&F Double Bottom Breakdown |
| P&F Descending Triple Bottom Breakdown |
| Moved Below Lower Price Channel |
| New 52-week Lows |
FOR STOCKCHARTS MEMBERS ONLY
Unlock custom technical alerts when you join StockCharts
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
FOR STOCKCHARTS MEMBERS ONLY
Unlock ChartLists to save and organize your charts when you join StockCharts
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.
